Mergers & Acquisitions

  • November 7, 2005

    SEC Actions Up Again For '05, Private Suits Way Down

    Empowered by Capitol Hill and flush with cash, the Securities and Exchange Commission is continuing to widen its campaign against corporate fraud, with the latest numbers for 2005 showing the agency will again beat its record from the previous year. The trend is offset by a dramatic decrease in filings of private securities fraud lawsuits, which typically complement SEC investigations.

  • November 7, 2005

    Charges Mount Against Guidant As J&J Deal Sours

    Embattled medical device maker Guidant Corporation can now add a federal investigation to its growing list of financial and legal worries, as the Securities and Exchange Commission has initiated a formal probe into the company’s product disclosures.

  • November 7, 2005

    Gold Mine Merger Bid Drove Insider Trading: SEC

    Stockholders used non-public information to illegally purchase call options in a Canadian gold company, just days before a $9.2 billion acquisition bid to create the world's largest gold mining company boosted its stock, according to a federal complaint by the U.S. Securities and Exchange Commission.

  • November 1, 2005

    Traders Stole Press Releases, SEC Claims

    A renegade Estonian financial-services firm stole press releases from more than 200 U.S. public companies and traded on the news before it reached the public, the Securities and Exchange Commission claimed in an emergency federal court action filed Monday.

  • October 25, 2005

    Merchant & Gould To Merge With Welsh & Katz

    Merchant & Gould and Welsh & Katz said Tuesday they would merge to create one of the largest intellectual property specialty firms in the United States.

  • October 17, 2005

    Barrier Therapeutics Misled Over Clinical Studies, Suit Says

    Barrier Therapeutics Inc. misled investors about the success of its clinical-stage biopharmaceuticals, according to a complaint filed by investors in federal court Friday.

  • October 18, 2005

    Refco Files For Bankruptcy, Agrees To Sell Futures Brokerage

    Just two months after an impressive $585 million initial public offering, Refco Inc. has filed for bankruptcy, agreeing to sell its core futures brokerage for $785 million in order to salvage some of its other subsidiaries.

  • October 17, 2005

    Class Action Suits Filed Against Refco Underwriters

    As futures broker Refco’s financial situation becomes increasingly dire, litigation against the company continues to mount, now encompassing the banks that underwrote Refco’s initial public offering.

  • October 13, 2005

    With An Eye On IP, Duane Morris Shakes Up Big Boys

    With the acquisition of California mid-sized firm Hancock Rothert & Bunshoft LLP, Duane Morris LLP is bolstering its California presence and taking another step toward becoming a coast-to-coast powerhouse.

  • October 10, 2005

    Patent Reform To Slash Litigation Costs, IPO Says

    Litigation costs will be slashed by a patent reform bill advancing on Capitol Hill, even though the bill has been watered down, says Herbert C. Wamsley, who heads up the influential Intellectual Property Owners Association.

  • September 14, 2005

    Ropes & Gray Helps Squash Bar-Code Patents

    With the wipe-out of inventor Jerome Lemelson’s controversial patent portfolio for the bar code scanner and industrial robotic vision, Ropes & Gray’s Fish & Neave unit can carve yet another notch in its belt.

  • September 13, 2005

    U.S. Executives Eye Jump In IP Litigation Costs Amid Weak Patent Quality

    U.S. companies expect to spend more money on patent litigation in coming years amid a continued decline in patent quality, a survey of executives shows.

  • August 12, 2005

    Federal Circuit Upholds Pfizer Patent, Blocks Generic Xalatan

    Pfizer Inc.’s glaucoma drug Xalatan is off limits to generics manufacturer Par Pharmaceutical Inc., following a decision in Pfizer’s favor by the U.S. Court of Appeals for the Federal Circuit.

  • August 9, 2005

    Ocean Tomo Launches IP Private Equity Fund

    Merchant bank Ocean Tomo has launched an investment fund to provide private equity capital and mezzanine debt to companies with undervalued intellectual property rights, including patents and trademarks.

  • August 8, 2005

    Sheppard Mullin Hires Media, IP Litigator From Coudert Brothers

    Kevin Goering, a seasoned media litigator with extensive experience in intellectual property, has left Coudert Brothers in New York to join Sheppard, Mullin, Richter & Hampton LLP as a partner in the Business Trial Practice Group.

  • July 28, 2005

    Teva-Ivax Merger Puts Spotlight On Authorized Generics

    Teva Pharmaceutical Industries Ltd.’s $7.4 billion purchase of Ivax Corp. will once again propel the Israeli drug maker past Novartis as a leader in the $58-billion worldwide market for generic drugs. But the deal will force Teva to take a stand on the controversial practice of “authorized generics,” analysts say.

  • July 18, 2005

    Kelley Drye Hires Pillsbury IP Partner

    Kelley Drye & Warren LLP has hired Pillsbury Winthrop Shaw Pittman partner Steven J. Moore as a partner in the firm’s intellectual property group.

  • July 11, 2005

    Japan Firms To Merge To Create IP Powerhouse

    Japanese law firm City-Yuwa Partners will absorb Ohba, Ozaki & Shimasue, one of the country’s leading intellectual property boutiques, as part of an effort to create a legal powerhouse for IP and technology services.

  • May 25, 2005

    Buchanan Ingersoll Acquires IP Boutique Burns Doane

    With the acquisition of Virginia-based IP powerhouse Burns, Doane, Swecker & Mathis by legal behemoth Buchanan Ingersoll, yet another IP boutique has thrown in the towel in a legal market increasingly dominated by large general-practice firms.

  • May 17, 2005

    Hunton & Williams Taps Kenyon Partner To Lead IP Group In New York

    Hunton & Williams LLP has hired Estelle J. Tsevdos and Donna M. Praiss from Kenyon & Kenyon and has tapped Tsevdos to lead the firm’s intellectual property practice in New York.